Ajanta Pharma Limited (APL) is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA. In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology and Pain management. It's brands hold leadership positions in sub-therapeutic areas they are present in. In Emerging Markets, company has presence in Africa, South East Asia, West Asia, and CIS on broader therapeutic segments such as antimalarial, gastro, antibiotics, cardiology, dermatology, pain management, etc. As on 31st December 2023, Ajanta has 44 ANDA approvals which are commercialised. It holds 2 tentative approvals and 22 ANDAs are awaiting US FDA approval. Company plans to file 6-8 ANDAs during the current financial year. Company has state-of-the-art research facilities for formulation and API development located at Mumbai, India. R&D capabilities are evident from number of 1st to market products launched by the company providing patients most needed compliance and convenience. A dedicated and focused team of over 800 scientists work for R&D, which is growing continuously. Ajanta has 6 formulations manufacturing facilities located in India. Besides that, it also has an API manufacturing facility located at Waluj, India. Ajanta’s flagship formulation facilities at Paithan (Maharashtra, India) and Dahej (Gujarat, India) have been approved by US FDA. Ajanta continuously invests in enhancing the existing manufacturing facilities to meet current cGMP requirements and also construct new facilities to meet company’s growth requirements. Please visit https://ajantapharma.com/ for more information.
View Top Employees from Ajanta Pharma LtdWebsite | https://ajantapharma.com/ |
Ticker | AJANTPHARM |
Revenue | $297 million |
Employees | 6,798 (3,806 on RocketReach) |
Founded | 1973 |
Address | 98 Ajanta House, Charkop, Kandivili West, Mumbai, Maharashtra 400067, IN |
Phone | +91 22 6606 1000 |
Fax | +91 22 6606 1200 |
Technologies |
JavaScript,
HTML,
PHP
+47 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Health Care, Speciality Branded Generics, Manufacturing, Medical, Generics, Pharmaceutical, Complex Formulations, Wellness |
Web Rank | 1 Million |
Keywords | Research And Development, Pharmaceutical Products, Pharmaceutical Manufacturing, Dermatology |
Competitors | Dexcel Pharma, Emcure Pharmaceuticals Limited, Glenmark Pharmaceuticals, Onyx scientific -a division of Ipca labs, Sun Farmaceutica do Brasil |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Ajanta Pharma Ltd employee's phone or email?
The Ajanta Pharma Ltd annual revenue was $297 million in 2024.
Satish Agrawal is the President of Ajanta Pharma Ltd.
3,806 people are employed at Ajanta Pharma Ltd.
Ajanta Pharma Ltd is based in Mumbai, Maharashtra.
The NAICS codes for Ajanta Pharma Ltd are [325, 32541, 32, 3254].
The SIC codes for Ajanta Pharma Ltd are [283, 28].